单位：[1]School of Public Affairs, Zhejiang University, Hangzhou, China[2]Department of Global Health, Peking University School of Public Health, Beijing, China[3]Key Laboratory of Carcinogenesis and Translational Research, Laboratory of Genetics, Ministry of Education, Peking University Cancer Hospital & Institute, Beijing, China[4]State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China[5]Columbia University, New York, NY, United States[6]Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China[7]Peking Union Medical College Hospital, Beijing, China[8]Heidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany[9]Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, United States[10]Africa Health Research Institute, Somkhele, South Africa[11]School of Public Policy and Management, Tsinghua University, Beijing, China[12]National Clinical Research Center for Respiratory Diseases, Beijing, China[13]Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China[14]Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, CA, United States[15]Chan Zuckerberg Biohub, San Francisco, CA, United States
Background: COVID-19 vaccines are in short supply worldwide. China was among the first countries to pledge supplies of the COVID-19 vaccine as a global public product, and to date, the country has provided more than 600 million vaccines to more than 200 countries and regions with low COVID-19 vaccination rates. Understanding the public's attitude in China toward the global distribution of COVID-19 vaccines could inform global and national decisions, policies, and debates. Objective: The aim of this study was to determine the attitudes of adults living in China regarding the global allocation of COVID-19 vaccines developed in China and how these attitudes vary across provinces and by sociodemographic characteristics. Methods: We conducted a cross-sectional online survey among adults registered with the survey company KuRunData. The survey asked participants 31 questions about their attitudes regarding the global allocation of COVID-19 vaccines developed in China. We disaggregated responses by province and sociodemographic characteristics. All analyses used survey sampling weights. Results: A total of 10,000 participants completed the questionnaire. Participants generally favored providing COVID-19 vaccines to foreign countries before fulfilling domestic needs (75.6%, 95% CI 74.6%-76.5%). Women (3778/4921, 76.8%; odds ratio 1.18, 95% CI 1.07-1.32; P=.002) and those living in rural areas (3123/4065, 76.8%; odds ratio 1.13, 95% CI 1.01-1.27; P=.03) were especially likely to hold this opinion. Most respondents preferred providing financial support through international platforms rather than directly offering support to individual countries (72.1%, 95% CI 71%-73.1%), while for vaccine products they preferred direct provision to relevant countries instead of via a delivery platform such as COVAX (77.3%, 95% CI 76.3%-78.2%). Conclusions: Among our survey sample, we found that adults are generally supportive of the international distribution of COVID-19 vaccines, which may encourage policy makers to support and implement the distribution of COVID-19 vaccines developed in China worldwide. Conducting similar surveys in other countries could help align policy makers' actions on COVID-19 vaccine distribution with the preferences of their constituencies.
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2021]版：
大类|3 区医学
小类|3 区公共卫生、环境卫生与职业卫生
最新[2025]版：
大类|3 区医学
小类|3 区公共卫生、环境卫生与职业卫生
JCR分区：
出版当年[2020]版：
Q1PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTHQ2PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
第一作者单位：[1]School of Public Affairs, Zhejiang University, Hangzhou, China
共同第一作者：
通讯作者：
通讯机构：[6]Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China[8]Heidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany[*1]Heidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Postfach 10 57 60 69047, Heidelberg, 69047, Germany
推荐引用方式(GB/T 7714)：
Yu Hanzhi,Du Runming,Wang Minmin,et al.Attitudes Toward the Global Allocation of Chinese COVID-19 Vaccines: Cross-sectional Online Survey of Adults Living in China[J].JMIR PUBLIC HEALTH and SURVEILLANCE.2022,8(6):
APA：
Yu, Hanzhi,Du, Runming,Wang, Minmin,Yu, Fengyun,Yang, Juntao...&Chen, Simiao.(2022).Attitudes Toward the Global Allocation of Chinese COVID-19 Vaccines: Cross-sectional Online Survey of Adults Living in China.JMIR PUBLIC HEALTH and SURVEILLANCE,8,(6)
MLA：
Yu, Hanzhi,et al."Attitudes Toward the Global Allocation of Chinese COVID-19 Vaccines: Cross-sectional Online Survey of Adults Living in China".JMIR PUBLIC HEALTH and SURVEILLANCE 8..6(2022)
